DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those treating ...
Dexcom announces the FDA approval of its over-the-counter glucose monitor, which will provide access to new medical resources for those lacking insurance. For those diagnosed with Type 2 Diabetes, a ...
DexCom projects 2025 revenue of $4.6 billion, representing 14% growth. This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results